1887

oa South African Family Practice - Symbicord(R) Maintenance and Reliever Treatment : a SMART new treatment standard for greater overall asthma control? : press release

 

Abstract

Symbicord(R) SMART (as-needed budesonide-formoterol combination) achieved a 45% reduction in severe exacerbations compared with terbutaline, partly due to formetorol's rapid- and long-acting effect. This was achieved with less recourse to additional maintenance ICS than seen in studies yielding far smaller reductions, possibly because declining lung-tissue concentrations of maintenance ICS may benefit from timely supplementation.

Loading

Article metrics loading...

/content/mp_safp/50/3/EJC80233
2008-05-01
2016-12-08
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error